Results 191 to 200 of about 96,097 (301)

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

Clinical &Experimental Allergy, EarlyView.
Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić, Marta Paolucci, Alessandro Streuli, David A. Melillo, Tianchi Jiang, Raffaela Campana, Claudia C. V. Lang, Thomas M. Kündig, Christian Steuer, Klaus Eyer, Pål Johansen   +10 more
wiley   +1 more source

Anaphylaxis Mimicking Severe Croup in Pediatric Patients: A Case Series. [PDF]

Cureus
Putta Nagarajan HD, P K R, Biswas MR, Rameshkumar T, Baig MA, Thirugnanasambandam N, Rameshkumar NS.   +6 more
europepmc   +1 more source

Diagnostic Performance of Biomarkers for Perioperative Hypersensitivity Reactions in Adults: A Systematic Review and Meta-Analysis on Tryptase and Histamine Dosing. [PDF]

Diagnostics (Basel)
Petrișor C, Constantinescu C, Szabo R, Dăncilă V, Onițiu-Gherman N.   +4 more
europepmc   +1 more source

Safety Practices During Hymenoptera Venom Immunotherapy: Single‐Centre Experience With Protocolised Intravenous Cannulation and Adrenaline Usage

Allergy, EarlyView.
Callum McWaters, Nicole Weibel, Elizabeth Leahy, Samantha Chan, Kymble Spriggs   +4 more
wiley   +1 more source

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, EarlyView.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

A Patient Education Intervention to Address Allergic Anaphylaxis-Related Quality-of-Life and Self-Efficacy. [PDF]

J Asthma Allergy
Belin C, Tomori C.
europepmc   +1 more source

Algorithms of Patient Selection for Allergen Immunotherapy

Allergy, EarlyView.
U. Petra Zieglmayer, Stefania Arasi, Thomas Eiwegger, Thilo Jakob, Ludger Klimek, Markus Ollert   +5 more
wiley   +1 more source

Adrenaline (epinephrine) nasal spray for severe allergic reactions. [PDF]

Aust Prescr
europepmc   +1 more source

Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections. [PDF]

J Clin Invest
Elwy A, Abdelrahman H, Specht J, Ewert GM, Friebus-Kardash J, Dhiman S, Falkenstein J, Christ TC, Wiebeck E, Shamoon A, Leimkühler NB, Gramberg T, Russ A, Kalinke U, Kuang F, Sutter K, Kopf M, Mack M, Hansen W, Nimmerjahn F, Lang KS.   +20 more
europepmc   +1 more source

Concordance of Skin Prick Testing and Allergen‐Specific IgE Testing in Children With Suspected Nut Allergy

Acta Paediatrica, EarlyView.
Pauliina Uusi‐Kokko, Lauri Lehtimäki, Jussi Karjalainen, Iida Ojaniemi, Heini Huhtala, Marjukka Härkönen, Jennifer L. P. Protudjer, Juho E. Kivistö   +7 more
wiley   +1 more source